News

Article

CPAN Year in Review 2023

CPAN Year in Review

In 2023, COA’s Patient Advocacy Network (CPAN) provided advocacy, education, and engagement opportunities in multiple ways. Key outcomes included 14 live advocacy events at community oncology practices including new CPAN chapter launches in Nevada, Ohio, and South Carolina. CPAN advocates and leadership stories were featured in multiple media publications, websites, social media, and COA’s Faces of Community Oncology campaign.

Click here to view CPAN’s Advocacy Year in Review.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of woman with text.
Image of man with text.
Ojjaara helps patients with myelofibrosis by reducing spleen size, easing symptoms, and improving anemia to boost independence from blood transfusions.
Image of Dr. Zhaoming Wang with text.
Enabling patients to generate CAR T-cells internally could cut kidney cancer therapy costs, explained Dr. Wayne Marasco of Dana-Farber Cancer Institute.
Image of woman with text.
Woman with text.
Q-TWiST may help patients with advanced kidney cancer and their doctors weigh treatment options by focusing on quality of life, not just disease control.
Kidney Cancer Research Embraces Biology-Driven Precision Approach
Related Content
Image of bonnie.
July 25th 2025

A Valuable Lesson I Learned While Living With Breast Cancer

Bonnie Annis
When I was diagnosed with breast cancer, I never dreamed I’d learn so many valuable life lessons along the way.
The Importance of Spotting Endometrial Cancer
March 18th 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
Image of blood cells.
July 25th 2025

FDA Approves Doptelet With Sprinkle Form for Pediatric Immune Thrombocytopenia

Spencer Feldman
Doptelet and new oral sprinkle granules is approved for children one year and older with chronic immune thrombocytopenia, showing 28% durable platelet response in study.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Image of kidney
July 24th 2025

Fotivda Alone Maintained Quality of Life in Kidney Cancer Study

Spencer Feldman
Fotivda preserved quality-of-life scores in kidney cancer, with better outcomes in second-line use and no added benefit from combining with Opdivo.
Illustration of woman.
July 24th 2025

Hiking Through Breast Cancer Treatment

Felicia Mitchell
Hiking helped to sustain me through cancer treatment, with its emphasis on fresh air, natural wonders, and the companionship of friends.